Viewing Study NCT00005857


Ignite Creation Date: 2025-12-24 @ 6:52 PM
Ignite Modification Date: 2026-01-25 @ 1:30 AM
Study NCT ID: NCT00005857
Status: COMPLETED
Last Update Posted: 2011-10-20
First Post: 2000-06-02
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Trastuzumab and Docetaxel in Treating Patients Who Have Metastatic Prostate Cancer That Is Refractory to Hormone Therapy
Sponsor: City of Hope Medical Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Prostate Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None stage IV prostate cancer View
None recurrent prostate cancer View